Goldshield Group - Pharmaceutical Products

Released 30/04/2009

Goldshield Group is a public company quoted on London’s main listing, selling and marketing pharmaceutical products, medical devices, consumer health products and lifestyle brands. Total revenue in year ending 31 March 2008 was £85 million. It has a global presence in 53 countries with primary focus in the UK, selected European countries and the US.

Goldshield Group is headquartered in Croydon, UK and has regional offices in the US, Ireland and India.

Goldshield Group was established in 1989 and listed on London Stock Exchange in 1998.     The Group is focused on building brands and products with consistent growth, reliable cash flows, sustainable profitability and a diverse product portfolio.

Today Goldshield Group is active in the following areas:

•   Selling an established portfolio of pharmaceutical products with long product life cycles (Codipar, Zapain, Macrobid/Macrodantin & Remodulin)
•   Building market leading brands in the consumer health arena (i.e. LIPObind and Appesat).
•   Offering rapid and comprehensive marketing access by operating multiple marketing channels and time-tested distribution relations.

More information about Goldshield Group Plc can be obtained at www.goldshieldplc.com

Goldshield Group Plc
No.1 Croydon
12-16 Addiscombe Road, Croydon
Surrey, CRO OXT
Tel:- +44 (0) 208 6498500
Fax:- + 44 (0) 20 8686 0807
Email: info@goldshieldplc.com

Return to businesses